DOI: 10.1055/s-00000097

Deutsche Zeitschrift für Onkologie

References

Franks LN, Ford BM, Fujiwara T. et al.
The tamoxifen derivative ridaifen-B is a high affinity selective CB2 receptor inverse agonist exhibiting anti-inflammatory and anti-osteoclastogenic effects.

Toxicol Appl Pharmacol 2018;
353: 31-42

Download Bibliographical Data

Search in:
Access: